Advancing Infusion Therapy: Innovation, Safety, and Best Practices

Join INS for Advancing Infusion Therapy: Innovation, Safety, and Best Practices, a virtual conference featuring five expert-led sessions focused on the latest advances in infusion therapy and vascular access. Explore evidence-based strategies for infection prevention, vascular access device selection, infusate compatibility, peripheral intravenous catheter care, and innovative approaches to improve patient safety and nursing efficiency. Gain practical insights and actionable strategies to enhance clinical practice and optimize patient outcomes across care settings. At the conclusion of the virtual conference, participants will be able to claim 5 contact hours and CRNI®s can earn up to 10 recertification units.

  • Contains 3 Component(s), Includes Credits

    Vascular access device (VAD) selection is a complex and evolving part of infusion therapy practice. The key foundational concept to VAD selection is vessel health and preservation, selecting the optimal VAD that will support administration of required infusion therapy while maintaining patient safety. It includes 4 basic segments: patient specific assessment and appropriate VAD selection, skilled clinician VAD insertion, VAD management to promote positive outcomes, and analyzing organizational data to identify areas for improvement. The choice of the correct VAD for placement is reliant on thorough understanding of VAD and infusate characteristics within the context of the individual patient’s condition and infusion therapy requirements. This session will review the risks and benefits of VAD options, the infusate components that increase injury risk, then apply those criteria to promote patient safety through to a case-based discussion from various clinical settings.

    Vascular access device (VAD) selection is a complex and evolving part of infusion therapy practice. The key foundational concept to VAD selection is vessel health and preservation, selecting the optimal VAD that will support administration of required infusion therapy while maintaining patient safety. It includes 4 basic segments: patient specific assessment and appropriate VAD selection, skilled clinician VAD insertion, VAD management to promote positive outcomes, and analyzing organizational data to identify areas for improvement. The choice of the correct VAD for placement is reliant on thorough understanding of VAD and infusate characteristics within the context of the individual patient’s condition and infusion therapy requirements. This session will review the risks and benefits of VAD options, the infusate components that increase injury risk, then apply those criteria to promote patient safety through to a case-based discussion from various clinical settings.

    Learning Objectives: At the conclusion of this session, learners will be able to:

    •    Describe characteristics of peripheral and central vascular access devices through risk/analysis perspective

    •    Identify infusate components that increase the risk of patient injury

    •    Apply VAD and infusate characteristics in a case scenario format to optimize patient safety

    Contact Hours: 1

    CRNI® RUs: 2

    Barb Nickel, APRN-CNS, CCRN, CRNI®

    Barb Nickel, APRN-CNS, CCRN, CRNI®

    Clinical Nurse Specialist

    CommonSpirit Health

    Barb Nickel, APRN-CNS, CCRN, CRNI® is a Clinical Nurse Specialist at a large health care system in the United States, responsible for staff development and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel has presented nationally and internationally and published in several peer-review journals on infusion-related topics. She was the chair of the 2024 INS Infusion Therapy Standards of Practice Committee, and is now chair of the 2027 Standards Committee. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.

  • Contains 3 Component(s), Includes Credits

    Intravascular catheters are used in nearly all healthcare settings and require frequent insertion, access, and maintenance. Each of these steps carries inherent infection risk. Recent regulatory changes and emerging infection prevention (IP) research have expanded surveillance and prevention efforts beyond central lines to include all vascular access devices (VADs), placing new expectations on vascular access teams (VATs). This session reviews evolving IP issues influencing VAD practice, including hospital-onset bacteremia and fungemia (HOB), leadership engagement, multidisciplinary team structures, and core prevention components across the device lifecycle. Updated research findings and expert guideline recommendations will be examined, with emphasis on post-insertion care, peripheral intravenous catheter risk, environmental contamination, and blood culture stewardship. Practical considerations for implementing sustainable prevention strategies and monitoring compliance will be discussed to support improved patient safety outcomes.

    Intravascular catheters are used in nearly all healthcare settings and require frequent insertion, access, and maintenance. Each of these steps carries inherent infection risk. Recent regulatory changes and emerging infection prevention (IP) research have expanded surveillance and prevention efforts beyond central lines to include all vascular access devices (VADs), placing new expectations on vascular access teams (VATs).

    This session reviews evolving IP issues influencing VAD practice, including hospital-onset bacteremia and fungemia (HOB), leadership engagement, multidisciplinary team structures, and core prevention components across the device lifecycle. Updated research findings and expert guideline recommendations will be examined, with emphasis on post-insertion care, peripheral intravenous catheter risk, environmental contamination, and blood culture stewardship. Practical considerations for implementing sustainable prevention strategies and monitoring compliance will be discussed to support improved patient safety outcomes.

    Learning Objectives: By the end of this session, participants will be able to: 

    • Describe the emerging infection prevention (IP) issues that will influence vascular access device (VAD) practice
    • Summarize new peer-reviewed studies and expert guideline recommendations that impact VAD practice
    • Review core components necessary in addressing the expansion in VAD surveillance and prevention activities

    Contact Hours: 1
    CRNI® RUs: 2

    Robert Garcia, MT(ASCP), CIC, FAPIC

    Robert Garcia, MT(ASCP), CIC, FAPIC

    Infection Prevention Consultant

    Enhanced Epidemiology LLC

    Robert Garcia is an infection preventionist/consultant and has been a member of the Association for Professionals in Infection Control and Epidemiology (APIC) since 1980. In 2016, he was selected as a fellow at the Association for Professionals in Infection Control and Epidemiology (APIC), a designation for experienced IPs who have had significant contributions to the field of infection prevention. He is the certification infection preventionist/director at nine hospitals in New York City and the principal researcher on the effectiveness of silver-hydrogel urinary catheters, chlorhexidine skin antisepsis, and comprehensive oral care. Robert is a current or former member of APIC’s National Strategic Planning Board, Education Committee, and/or CBIC, as well as a trainer for APIC’s EPI Clinical Course. He is a contributor to APIC’s Text of Infection Control and Epidemiology; was a reviewer for the 2005 HICPAC Guidelines on Isolation; and since 2001 has been an editorial board member and/or reviewer for the American Journal of Infection Control, where in 2016 he was ranked among the top 25th percentile of reviewers. He has more than 100 publications and media interviews ranging from institutional costs of infection to prevention of HAIs to environmental contamination to microbiology to reducing occupational exposures.

  • Contains 3 Component(s), Includes Credits

    Patients with hypercoagulable conditions present unique challenges for vascular access clinicians. Choosing the most appropriate vascular access device (VAD) requires balancing infusion therapy needs, vessel health preservation, and minimizing thrombosis risk. This session will explore hypercoagulable disease states, such as cancer-associated thrombosis, antiphospholipid antibody syndrome, and inherited thrombophilias, and discuss how each impacts device selection, dwell time, and maintenance practices. Attendees will review current evidence, clinical guidelines, and case scenarios that highlight the intersection of pathophysiology, device choice, and patient outcomes.

    Patients with hypercoagulable conditions present unique challenges for vascular access clinicians. Choosing the most appropriate vascular access device (VAD) requires balancing infusion therapy needs, vessel health preservation, and minimizing thrombosis risk. This session will explore hypercoagulable disease states, such as cancer-associated thrombosis, antiphospholipid antibody syndrome, and inherited thrombophilias, and discuss how each impacts device selection, dwell time, and maintenance practices. Attendees will review current evidence, clinical guidelines, and case scenarios that highlight the intersection of pathophysiology, device choice, and patient outcomes.

    Learning ObjectivesAt the conclusion of this session, learners will be able to:  

    • Identify common hypercoagulable disease states encountered in infusion and vascular access practice 
    • Analyze how hypercoagulability influences the risk profile for peripherally inserted central catheters (PICCs)midline catheters, ports, and tunneled catheters 
    • Apply evidence-based strategies to guide VAD selection and management for patients with elevated thrombotic risk 
    • Integrate risk-mitigation approaches into patient education, insertion practices, and ongoing device maintenance 

    Contact Hours: 1
    CRNI® RUs: 2

    Britt Meyer, PhD, RN, CRNI®, VA-BC, NE-BC

    Britt Meyer, PhD, RN, CRNI®, VA-BC, NE-BC

    Nurse Manager Operations Vascular Access Team

    Duke Hospital

    Britt Meyer, PhD, RN, CRNI®, VA-BC, NE-BC, chair of the Infusion Nurses Certification Corporation (INCC), leads the vascular access team at Duke University Hospital and presents nationally and internationally on a variety of infusion and vascular access topics. She is well-published in the specialty and is passionate about empowering clinicians to provide safe and effective care. She also serves as an adjunct faculty member for the East Carolina University School of Nursing and is a member of the INS Standards Committee for the 10th edition.

  • Contains 3 Component(s), Includes Credits

    Peripheral intravenous infiltrations and extravasations (PIVIEs) remain a significant source of preventable harm, patient distress, and healthcare cost, especially in pediatric settings, where families often cite intravenous (IV) starts and failures as the most stressful part of a hospitalization. With over 80% of hospitalized patients requiring a peripheral intravenous catheter (PIVC), proactive prevention strategies are essential. This session introduces and discusses the P.O.K.E. initiative (Previous PIVIE, Oral transition, Keep it, Educate PIV plan to family and team), a structured communication tool designed to reduce PIVIE rates through interdisciplinary collaboration and family engagement.

    Peripheral intravenous infiltrations and extravasations (PIVIEs) remain a significant source of preventable harm, patient distress, and healthcare cost, especially in pediatric settings, where families often cite intravenous (IV) starts and failures as the most stressful part of a hospitalization. With over 80% of hospitalized patients requiring a peripheral intravenous catheter (PIVC), proactive prevention strategies are essential. This session introduces and discusses the P.O.K.E. initiative (Previous PIVIE, Oral transition, Keep it, Educate PIV plan to family and team), a structured communication tool designed to reduce PIVIE rates through interdisciplinary collaboration and family engagement.  

    Learning Objectives: At the conclusion of this session, learners will be able to:  

    • Understand the complications associated with PIVIE and their impact on the child, the family, and the health care system 
    • Identify evidence-based tools for the prevention of PIVIE 
    • Evaluate current PIVIE prevention strategies implemented to determine alignment with evidence-based best practices and identify opportunities for improvement 
    • Recognize key risk factors that contribute to its occurrence in pediatric patients 

    Contact Hours: 1
    CRNI® RUs: 2

    Julie Marshall, DNP, RN, CCM, CNE, PED-BC

    Julie Marshall, DNP, RN, CCM, CNE, PED-BC

    Clinical Practice Specialist

    Children's Hospital Colorado

    Julie Ann Marshall, DNP, RN, CCM, CNE, PED-BC, has been a pediatric nurse for over 20 years and is certified in pediatric nursing, case management, and as a certified nurse educator. She is celebrating her 20th year at Children’s Colorado and serves as the Clinical Practice Specialist for MedSurg in Colorado Springs. Her passion is to bridge evidence-based practice and quality improvement work to clinical nurses at the bedside to empower all nurses as change agents to drive improved outcomes. Dr Marshall’s current focuses are pediatric fall prevention, nurse-led rounds, and pediatric needle pain mitigation.

    She has many years of clinical nursing experience, teaching practice to nursing students, new graduate nurses in a residency program, online distance learning, hospital-based and academic-based education. Dr Marshall is a member of the Association of Pediatric Hematology/Oncology Nurses and the Society of Pediatric Nurses. She has completed many quality improvement and evidence-based practice projects and has disseminated at national conferences and locally in Colorado. 

    Dr Marshall’s passion is to bridge evidence-based practice and quality improvement work to clinical nurses at the bedside to empower all nurses as change agents to drive improved outcomes. She strongly believes that all nurses are leaders, with or without a title. Her mission is to continue to mentor, develop, teach, and model the profession of pediatric nursing for future and current nurses, completing this through a dedication to lifelong learning and championing a safe and just culture. Dr Marshall has also served on global medical mission trips and local medical missions, and volunteers at a local hospice agency to provide companionship for the dying. 

    Jessica L. Perdue, DNP, MS, RN, NPD-BC, CPN

    Jessica L. Perdue, DNP, MS, RN, NPD-BC, CPN

    Clinical Practice Specialist

    Children's Hospital Colorado

    Jessica L. Perdue, DNP, MS, RN, NPD-BC, CPN, is a Clinical Practice Specialist at Children’s Hospital Colorado with more than 25 years of pediatric nursing experience and focused expertise in infusion therapy-related quality improvement and patient safety. 

    Dr Perdue has led organization-wide initiatives to reduce peripheral intravenous infiltration and extravasation (PIVIE) through standardized assessment, workflow redesign, policy revision, and competency-based education across emergency, urgent care, and inpatient settings. Her work emphasizes data-driven quality improvement, interdisciplinary collaboration, and alignment with INS standards.

  • Contains 3 Component(s), Includes Credits

    Luer lock connections are essential for managing vascular access devices and equipment used in infusion therapies across inpatient, outpatient, and home care settings. However, due to the difficulty of disconnecting some of these devices, many workarounds have been implemented, leading to possible complications such as medication errors and risk of infection. By learning proper connection and disconnection procedures, these complications, including central line associated bloodstream infections (CLABSI), can be reduced and even prevented. This session will discuss the application of systems-based thinking to identify and address disconnection challenges, tool improvisation, and training gaps, resulting in a nurse-centered prototype designed to reduce catheter-related complications, improve patient safety and satisfaction, and decrease health care costs.

    Luer lock connections are essential for managing vascular access devices and equipment used in infusion therapies across inpatient, outpatient, and home care settings.  However, due to the difficulty of disconnecting some of these devices, many workarounds have been implemented, leading to possible complications such as medication errors and risk of infection. By learning proper connection and disconnection procedures, these complications, including central line associated bloodstream infections (CLABSI), can be reduced and even prevented. This session will discuss the application of systems-based thinking to identify and address disconnection challenges, tool improvisation, and training gaps, resulting in a nurse-centered prototype designed to reduce catheter-related complications, improve patient safety and satisfaction, and decrease health care costs. 

    Learning Objectives: At the conclusion of this session, learners will be able to:  

    • Explain how tool availability and training may influence nurses’ use of workarounds with catheter luer disconnections 
    • Describe the impact of workarounds on patient safety, catheter management, and nursing workflow efficiency 
    • Evaluate the benefits of a nurse-centered disconnection device in reducing health care costs and improving patient safety and patient satisfaction outcomes 
    • Apply evidence-based and systems-based strategies to enhance catheter disconnection practices, including training opportunities across various health care settings 

    Contact Hours: 1
    CRNI® RUs: 2

    Amy Cole, PhD, MPS, MS, PMP

    Amy Cole, PhD, MPS, MS, PMP

    Human Factors and Health Services Researcher

    UNC School of Medicine

    Amy C. Cole, PhD, MPS, MS, PMP, is a Research Assistant Professor at the University of North Carolina at Chapel Hill, with appointments in the School of Information and Library Science, the Carolina Health Informatics Program, and the Division of Healthcare Engineering in the School of Medicine. She is a human factors and health services researcher whose work spans medical device innovation, digital health, patient‑clinician communication, and values‑driven decision support. Dr Cole focuses on designing and evaluating technologies that improve safety, usability, and overall care experiences for patients, caregivers, and clinicians.

    Her portfolio is supported by competitive funding and recognitions across device and digital health innovation, among them a National Center for Advancing Translational Sciences (NIH [NCATS]) pilot award for prototype development and a U.S. National Science Foundation Innovation Corps (NSF I‑Corps™) grant for customer discovery. She has received national honors, such as the Oley Foundation’s Top Clinical Research Paper Award, the Society for Medical Decision Making’ (SMDM) Anne Stiggelbout Award, and the Dennis Revicki Memorial Award, and was selected for the National Science Foundation (NSF) National Artificial Intelligence Research Resource (NAIRR) Pilot cohort.

    Dr Cole serves nationally as a member of the Patient-Centered Outcomes Research Institute (PCORI) Rare Disease Advisory Panel and on the SMDM’s Patient Advocacy Council, contributing to national efforts to center patient perspectives in research and innovation.

    An experienced speaker, she has presented at leading conferences including International Society for Quality of Life Research (ISOQOL), SMDM, the International Forum on Quality and Safety in Healthcare, and Association of American Medical Colleges (AAMC). She regularly delivers invited talks and workshops on patient‑centered care, human factors, and digital health. Dr Cole’s research often involves simulation‑based methods, co‑design with diverse stakeholders, and mixed‑methods approaches to evaluate and refine innovative health care technologies. She also directs an internship program in patient‑centered care and systems innovation. Her work is driven by a commitment to advancing innovative, patient‑centered solutions that strengthen health care systems and improve outcomes across diverse clinical settings.